Which contrast agent is associated with kidney function risk in CT scans?

Which contrast agent is associated with kidney function risk in CT scans?

• A. Iodine-based contrast
• B. Gadolinium-based contrast
• C. Saline solution
• D. Air

Answer: (A)

Iodine-based contrast used in CT scans brightens tissues by increasing X-ray attenuation, but it can also affect kidney function. These iodinated contrasts can cause contrast-induced nephropathy, especially in patients with preexisting kidney disease, dehydration, diabetes, or those taking other nephrotoxic medications. The kidney burden comes from the agent being filtered and processed by the kidneys, which can lead to a temporary drop in kidney function after exposure. To reduce risk, clinicians assess baseline kidney function, use the lowest effective dose, ensure adequate hydration, and prefer agents with lower nephrotoxicity when possible. Gadolinium-based contrast is used for MRI, not CT, and has different kidney risks; saline and air do not serve as CT contrasts.

Iodine-based contrast used in CT scans brightens tissues by increasing X-ray attenuation, but it can also affect kidney function. These iodinated contrasts can cause contrast-induced nephropathy, especially in patients with preexisting kidney disease, dehydration, diabetes, or those taking other nephrotoxic medications. The kidney burden comes from the agent being filtered and processed by the kidneys, which can lead to a temporary drop in kidney function after exposure. To reduce risk, clinicians assess baseline kidney function, use the lowest effective dose, ensure adequate hydration, and prefer agents with lower nephrotoxicity when possible. Gadolinium-based contrast is used for MRI, not CT, and has different kidney risks; saline and air do not serve as CT contrasts.